Schwartz Jeffrey Lawrence (CIK 1702957) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-10). Recent activity: Sell KMTS (3,890 shares), Buy KMTS (7,217 shares), Buy KMTS (10,909 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-10 | KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | Director | Sell | 3,890 | $97,942 |
| 2026-09-10 | KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | Director | Buy | 7,217 | $0 |
| 2025-09-08 | KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | Director | Buy | 10,909 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-10